Cargando…

Defibrillators for prevention from sudden cardiac death: is it that easy?

Detalles Bibliográficos
Autores principales:	Duncker, David, Veltmann, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400471/ https://www.ncbi.nlm.nih.gov/pubmed/32236539 http://dx.doi.org/10.1093/europace/euaa044

Ejemplares similares

Subcutaneous implantable cardioverter-defibrillator (S-ICD) for secondary prevention of sudden cardiac death
por: Kempa, Maciej, et al.
Publicado: (2016)

Role of the Wearable Defibrillator in Newly Diagnosed Heart Failure
por: Duncker, David, et al.
Publicado: (2018)

The usefulness of cardiac magnetic resonance in prevention of sudden cardiac death after myocardial infarction
por: İpek, Esra Gücük
Publicado: (2015)

Implantable Cardioverter‐Defibrillators for Secondary Prevention of Sudden Cardiac Death: A Review
por: Borne, Ryan T., et al.
Publicado: (2017)

Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator—The PROLONG Study
por: Duncker, David, et al.
Publicado: (2017)

Wearable Cardioverter-defibrillators for the Prevention of Sudden Cardiac Death: A Meta-analysis
por: Nguyen, Elaine, et al.
Publicado: (2018)

Use of Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death in Asia
por: Ueda, Nobuhiko, et al.
Publicado: (2023)

Enhancing CPR training and installation of defibrillators in public places – A solution to tackle sudden cardiac arrest
por: Suvvari, Tarun Kumar, et al.
Publicado: (2023)

Preventing Sudden Death And The Use Of Prophylactic Implanted Defibrillators
por: Ray, Indranill Basu
Publicado: (2003)

Arrhythmias and sudden cardiac death in the COVID-19 pandemic
por: Kuck, Karl-Heinz
Publicado: (2020)

Potential causes of sudden cardiac death in nemaline myopathy
por: Finsterer, Josef, et al.
Publicado: (2015)

Sudden cardiac death in physicians: an alarming problem in China
por: Shi, Xinmiao, et al.
Publicado: (2018)

The unfriendly side of “happy hypoxaemia”: Sudden cardiac death
por: Serbanescu-Kele Apor de Zalán, C.M.C., et al.
Publicado: (2022)

Prevention of sudden cardiac death by the wearable cardioverter defibrillator in a young patient with cardiac sarcoidosis
por: Andrié, René, et al.
Publicado: (2017)

Sports, energy drinks, and sudden cardiac death: stimulant cardiac syndrome
por: Kaşıkçıoğlu, Erdem
Publicado: (2017)

Sudden Cardiac Death and Its Prevention Ways among Athletes According to Iranian Traditional Medicine
por: SIAHPOOSH, Marzieh-Baygom, et al.
Publicado: (2013)

Who Benefits From a Defibrillator—Balancing the Risk of Sudden Versus Non-sudden Death
por: Beggs, Simon A. S., et al.
Publicado: (2018)

Sudden cardiac death and atrial depolarization in coronary artery disease
por: Babayiğit, Erdi, et al.
Publicado: (2023)

Implantable Defibrillators for Secondary Prevention of Sudden Cardiac Death in Cardiac Surgery Patients With Perioperative Ventricular Arrhythmias
por: Nageh, Maged F., et al.
Publicado: (2014)

Strategies for preventing sudden unexpected COVID-19 deaths at home
por: Matsuyama, Tasuku, et al.
Publicado: (2020)

Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator
por: Skowasch, Dirk, et al.
Publicado: (2018)

Predictors of appropriate therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death
por: Ahmed, Imdad, et al.
Publicado: (2010)

Ventricular tachycardia prediction in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death
por: Lebedeva, Viktoria K., et al.
Publicado: (2018)

Subcutaneous Implantable Cardioverter Defibrillators for the Prevention of Sudden Cardiac Death: Pediatric Single-Center Experience
por: Wieniawski, Piotr, et al.
Publicado: (2022)

Sudden Intrauterine Unexpected Fetal Death Syndrome and Sudden Infant Death Syndrome
por: Pusiol, Teresa, et al.
Publicado: (2014)

Experience With the Wearable Cardioverter-Defibrillator in Patients at High Risk for Sudden Cardiac Death
por: Wäßnig, Nadine K., et al.
Publicado: (2016)

To the Editor — Are we close to a major impact on prevention of sudden cardiac death among coronary artery disease patients?
por: Doundoulakis, Ioannis, et al.
Publicado: (2022)

Underutilization of Implantable Cardioverter Defibrillator in Primary Prevention of Sudden Cardiac Arrest
por: Lakshmanadoss, Umashankar, et al.
Publicado: (2011)

Sudden cardiac death and atrial depolarization in coronary artery disease—Authors’ reply
por: Perkiömäki, Juha S, et al.
Publicado: (2023)

Sudden Death Following Cranioplasty
por: Honeybul, Stephen
Publicado: (2016)

Effects and Complications of Subcutaneous Implantable Cardioverter-Defibrillator in the Prevention of Sudden Cardiac Death: A Narrative Review
por: Pagore, Prasad A, et al.
Publicado: (2022)

Reply to the Editor — Are we close to a major impact on prevention of sudden cardiac death among coronary artery disease patients?
por: Downey, Michael C., et al.
Publicado: (2022)

Usage of the wearable cardioverter-defibrillator during pregnancy
por: Olic, J.-Jacqueline, et al.
Publicado: (2022)

Extended use of the wearable cardioverter-defibrillator in patients at risk for sudden cardiac death
por: Kutyifa, Valentina, et al.
Publicado: (2018)

Prevention of Sudden Cardiac Death
por: Francis, Johnson
Publicado: (2011)

Preventing Sudden Death with Implantable Defibrillators in Octogenarians: Too Much Too Late?
por: John, Roy M.
Publicado: (2016)

Efficacy of Implantable Cardioverter-defibrillators for Secondary Prevention of Sudden Cardiac Death in Patients with End-stage Renal Disease
por: Payne, Taylor, et al.
Publicado: (2020)

Single‐ Versus Dual‐Chamber Implantable Cardioverter‐Defibrillator for Primary Prevention of Sudden Cardiac Death in the United States
por: Margolis, Gilad, et al.
Publicado: (2023)

Depressive Symptoms and Quality of Life in Patients With Heart Failure and an Implantable Cardioverter-Defibrillator
por: Zormpas, Christos, et al.
Publicado: (2022)

Sudden cardiac death due to β(2)-agonist therapy: is a genetic basis overlooked?
por: Yalta, K, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_5h7ma64olksdjljhkojp4rjo3h